Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Cemtrex announced that its subsidiary Invocon, Inc. has been selected for a Phase I SBIR contract by the U.S. Navy's Naval Sea Systems Command to develop modular mine warfare components, validating Invocon's technical capabilities and expanding Cemtrex's role in defense aerospace and naval technology sectors.
VivoPower PLC, a Nasdaq-listed global developer of powered land and data center infrastructure for AI compute applications, announced the appointment of Khadija Mustafa, a seasoned AI business leader from Microsoft and G42, to its Advisory Council. Her extensive experience in AI strategy, international partnerships, and technology commercialization…
Moleculin Biotech released a CEO Corner segment focusing on the differentiated safety profile of its lead drug candidate, Annamycin, designed to avoid cardiotoxicity common with traditional anthracyclines. The company is conducting a pivotal Phase 3 MIRACLE trial for relapsed or refractory acute myeloid leukemia (AML), positioning Annamycin as a pr…
ZenaTech, Inc. announced plans to build a drone testing facility and operational deployment in Ukraine, leveraging the active drone warfare environment for real-world validation of its Interceptor defense systems. This initiative complements ZenaTech's planned manufacturing facility in Ukraine, aimed at producing cost-effective counter-UAS platform…
Milestone Pharmaceuticals Inc., a biopharmaceutical company specializing in cardiovascular medicines, announced its management will present at the 25th Annual Needham Virtual Healthcare Conference. The company is advancing its lead FDA-approved product CARDAMYST™ (etripamil) nasal spray for treating paroxysmal supraventricular tachycardia and is de…
DeFi Development Corp. (Nasdaq: DFDV) released its March 2026 recap detailing robust financial performance with +442% revenue growth in 2025, growth in its Solana-based Digital Asset Treasury platform, and acceleration in adoption of its liquid staking token dfdvSOL. The company expanded research on AI-driven demand for Solana, advanced its strateg…
Prairie Operating Co., a Houston-based independent energy company focused on oil and natural gas in the Denver-Julesburg Basin, announced an extension of the Series F Convertible Preferred Stock warrant issuance date from April 7 to April 9, 2026. This extension allows the parties additional time for ongoing discussions with no guarantee of a defin…
BioRestorative Therapies, a Nasdaq-listed regenerative medicine company, has formed a strategic collaboration with brand strategy firm 203 Creates to develop and commercialize a biocosmeceutical product portfolio. This partnership aims to create a strong brand identity and a global go-to-market strategy to launch BioRestorative's BioX™ platform, fe…
Jupiter Neurosciences has appointed Kristopher Fishman and Sanjiv Lal to its Nugevia™ advisory board, aiming to leverage their expertise and networks in compounding pharmacies and wellness channels. This strategic move targets an addressable U.S. nutraceutical market over $1.5 billion and supports the expansion of Nugevia™ – a consumer longevity pr…
Polyrizon Ltd., a pre-clinical-stage biotechnology company developing intranasal protective solutions, has entered agreements to raise approximately $3.5 million through a registered direct offering and a private placement with a single institutional investor. The offering includes the sale of Ordinary Shares and pre-funded warrants, which are inte…
22nd Century Group, Inc. announced progress on its 100mm VLN® reduced nicotine cigarette, aiming to expand its unique FDA-authorized low nicotine combustible cigarette portfolio through additional PMTA submissions. The company plans a broad product range and licensing strategy to reach wider consumer preferences and increase retail penetration, rei…
CRISPR Therapeutics announced that its senior management will present at the 25th Annual Needham Virtual Healthcare Conference. The company, a leader in gene-editing biopharmaceuticals, has developed CASGEVY®, the first approved CRISPR-based therapy for sickle cell disease and beta thalassemia, and continues to advance a diverse pipeline across mul…
IP Strategy Holdings spotlights Aria Protocol's partnership with artist RESCENE to release the single "Busy Boy" using the Story blockchain infrastructure. This release introduces a new model of music ownership where royalties flow to $APL token holders from the start of a song's lifecycle, enhancing transparency and liquidity in music IP monetizat…
JFB Construction Holdings announced a 32% increase in 2025 year-end revenues compared to 2024, driven by diverse construction projects. The company is merging with XTEND, a leader in AI-driven autonomous defense robotics, in a $1.5 billion transaction expected to close by Q2 2026. The combined entity, to be renamed XTEND AI Robotics and listed on N…
Corbus Pharmaceuticals announced broad agreement with the FDA on registration trial designs for CRB-701, their next-generation ADC targeting Nectin-4, enabling potential accelerated approval for second-line treatment of head and neck squamous cell carcinoma (HNSCC) and cervical cancer. The company plans to initiate registrational studies in mid-202…
Recursion (Nasdaq: RXRX), a clinical-stage TechBio company specializing in AI-driven drug discovery, announced its participation in the 25th Annual Needham Virtual Healthcare Conference and the Bank of America Health Care Conference in 2026. The company highlights its AI-native platform, Recursion OS, which integrates biology, chemistry, and clinic…
Fusion Fuel Green PLC, via its subsidiary Al Shola Gas, has been awarded approximately $1.14 million in new LPG engineering subcontracts for multiple residential and mixed-use developments in Dubai, including a flagship dual-tower project valued at $0.5 million. These contracts support installation and commissioning of centralized LPG systems acros…
Evaxion A/S announced the completion of the one-year extension phase of its phase 2 trial for EVX-01, a personalized cancer vaccine developed with its AI-Immunology platform targeting advanced melanoma. Early trial results show a 75% objective response rate with durable clinical benefits and strong immune activation, underpinning the vaccine’s pote…
Enphase Energy, a leader in solar microinverter technology and energy management systems, announced it will hold a conference call and webcast on April 28, 2026, to review its first quarter financial results ending March 31, 2026. The company highlighted its global footprint and innovation in solar energy solutions, with over 5.1 million systems de…
Virtuix Inc. announced that CEO Jan Goetgeluk will present at a private investor forum at Mar-a-Lago and an investor lunch in West Palm Beach on April 16, 2026. The presentations will focus on Virtuix's expanding traction in the defense sector through sales and partnerships with the U.S. Army, Navy, and Marine Corps, its participation in Meta's 'Ma…
Anavex Life Sciences Corp., a Nasdaq-listed clinical-stage biopharmaceutical company, announced its upcoming presentation at the 25th Annual Needham Virtual Healthcare Conference, where its CEO and management team will discuss its pipeline of treatments targeting Alzheimer's, Parkinson's disease, Rett syndrome, and other CNS disorders. The company …
Bread Financial Holdings, a US-based tech-forward financial services company, has scheduled its first quarter 2026 earnings conference call for April 23, 2026. The company offers personalized payment, lending, and saving solutions, serving millions of consumers with co-brand, private label credit cards, and other financial products.
Skye Bioscience, a clinical-stage biotech company, announced its upcoming presentation at the GLP-1-Based Therapeutics Summit. The company will showcase its development of nimacimab, a first-in-class, peripherally-restricted monoclonal antibody targeting the CB1 receptor to provide additive benefits to GLP-1 therapies for obesity and metabolic heal…
AC Immune has amended its 2018 collaboration agreement with Eli Lilly to continue developing Morphomer® Tau aggregation inhibitors for Alzheimer's disease and other neurodegenerative conditions. The amendment reflects significant progress with Morphomer small molecules, adding new lead and backup candidates, and includes milestone payments totaling…
MediWound Ltd. (Nasdaq: MDWD) announced presentations of new data on its enzymatic wound care product EscharEx at three leading wound care conferences in 2026. The data highlights EscharEx's unique mechanism of action, effective clinical performance in venous leg ulcers (VLUs), and its comparative advantages over the current standard, SANTYL. The f…
